DURLAMDA

Swiss trademark · 658364 · Word mark · Deleted

Register entry

Registration number
658364
Application number
51549/2014
Status
Deleted
Type
Word mark
Filed
Feb 7, 2014
Registered
May 9, 2014
Published
May 9, 2014
Deleted
Aug 30, 2024
Reason
Not renewed
Priority
04.09.2013 US
Language of procedure
German
Source
Swissreg

Goods and services

Pharmaceuticals

Pharmazeutische Präparate für den menschlichen Gebrauch für die Behandlung und Vorbeugung von Hepatitis.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 30, 2024

    Deleted, not renewed

    Status of protective title
    Active → Cancelled
    Cancellation date
    30.08.2024
    Cause for cancellation
    Cancellation due to non-renewal

    Published in Swissreg on 30.08.2024

  2. Dec 18, 2023

    Agent’s address changed

    Representative
    E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich → E. Blum & Co. AG, Hofwiesenstrasse 349, 8050 Zürich

    Published in Swissreg on 18.12.2023

  3. May 9, 2014

    Registered

    Published in Swissreg on 09.05.2014

Parties

Holder

Bristol-Myers Squibb Company

345 Park Avenue, New York, NY 10154, US

Agent

E. Blum & Co. AG

Hofwiesenstrasse 349, 8050 Zürich

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.